Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Ormat Technologies	ORA	24. avr 2025	72.72	+1.51
Orrstown Financial Services	ORRF	24. avr 2025	28.79	+1.70
Orthofix Medical	OFIX	24. avr 2025	13.95	+3.87
OrthoPediatrics	KIDS	24. avr 2025	21.76	+4.77
Oruka Therapeutics	ORKA	24. avr 2025	10.50	-0.76
OS Therapies	OSTX	24. avr 2025	1.61	+3.87
Oscar Health A	OSCR	24. avr 2025	12.03	+0.17
Oshkosh	OSK	24. avr 2025	88.71	+5.16
OSI Systems	OSIS	24. avr 2025	202.31	+4.51
Osisko Development	ODV	24. avr 2025	1.70	+5.59
Osisko Gold Royalties	OR	24. avr 2025	23.37	+2.05
OSR Holdings	OSRH	24. avr 2025	1.38	0.00
Ostin Technology Group	OST	24. avr 2025	2.77	+32.54
Otis Worldwide	OTIS	24. avr 2025	92.74	+0.48
Otter Tail	OTTR	24. avr 2025	79.13	+0.23
Ouster	OUST	24. avr 2025	7.72	+9.35
Outbrain	OB	24. avr 2025	3.80	+4.11
Outfront Media	OUT	24. avr 2025	14.99	+2.32
Outlook Therapeutics	OTLK	24. avr 2025	1.55	0.00
Outset Medical	OM	24. avr 2025	10.86	-3.47
Ovid Therapeutics	OVID	24. avr 2025	0.34	+3.63
Ovintiv	OVV	24. avr 2025	34.53	+2.62
Owens & Minor	OMI	24. avr 2025	6.97	+4.81
Owens Corning	OC	24. avr 2025	143.96	+4.19
Owlet A	OWLT	24. avr 2025	3.44	-2.27
Oxbridge Re	OXBR	24. avr 2025	1.29	-5.98
Oxford Industries	OXM	24. avr 2025	51.34	+8.34
Oxford Lane Capital	OXLC	24. avr 2025	4.54	+1.34
Oxford Lane Capital 2027 Pref	OXLCP	24. avr 2025	24.23	+0.54
Oxford Square Capital	OXSQ	24. avr 2025	2.44	0.00

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.